"We can't cut ourselves off and we don't now want China to cut us off, so we have to do this in a systematic way,” a US lawmaker said

US intelligence officials say Chinese pharma companies are risking national security at a time when Washington is considering multiple bills targeting those firms access to funds

Shares of WuXi Biologics plunge 25% after Commerce Dept adds 33 Chinese entities to its 'unverified list', which requires exporters to go through more procedures before shipping goods

Shares plunged nearly 20% on Wednesday after a report that Washington was considering blacklisting Chinese biotechnology groups